Search results for "cornea"

showing 10 items of 404 documents

Crystalline subtype of pre-descemetic corneal dystrophy.

2014

Purpose: To report corneal findings in a familial case of the crystalline subtype of pre- Descemetic corneal dystrophy. Case Report: A 19-year-old girl and her 44-year-old mother were found to have asymptomatic, bilateral, punctiform and multi-colored crystalline opacities across the whole posterior layer of the corneas. Endothelial specular microscopy revealed the presence of white round flecks located at different levels anterior to the endothelium. No systemic abnormalities or medications could be related to account for these findings. Conclusion: To the best of our knowledge, this is the third familial report of this rare corneal disorder. Differential diagnosis may include Schnyder cor…

Crystalline Subtype Pre-Descemetic Corneal Dystrophylcsh:Ophthalmologygenetic structureslcsh:RE1-994Crystalline Corneal Deposition Specular MicroscopyCase ReportCrystalline Subtype Pre-Descemetic Corneal Dystrophy; Crystalline Corneal Deposition Specular Microscopysense organseye diseases
researchProduct

Efficacy and safety study of an eyelid gel after repeated nocturnal application in healthy contact lens users and non-users

2020

Purpose: To evaluate skin biocompatibility of a nighttime hydrating eyelid gel and possible ocular surface effects in contact lens users (CLU) and non-contact lens users (NCLU). The formulation is registered as a medical device as Tridocosahexaenoine-AOX® (TDHA-AOX) (a concentrated DHA triglyceride), containing also hyaluronic acid (HA). Methods: A prospective, randomized, masked clinical trial was performed with 62 participants of both sexes, aged 20–70 years, split into: (1) CLU (n = 30) and (2) NCLU (n = 32). All participants were instructed to apply a single dose of the moisturizing gel (containing TDHA-AOX and HA) nightly to the upper and inner eyelids of their right eye (RE) only, and…

DHA docosahexaenoic acidNon usersFBUT fluorescein break-up timeALA alpha linolenic acidTDAH-AOX tridocosahexaenoin-antioxidantNCLU non contact lens users0302 clinical medicineLC PUFAs long chain polyunsaturated fatty acidsMedicineCL contact lensesOS ocular surfaceHA hyaluronic acidOSDI ocular surface disease indexDE dry eyeCLU contact lens usersCLDEQ contact lens dry eye questionnaireVEGF vascular endothelial growth factorDocosahexaenoic acidBMC biomicroscopymedicine.anatomical_structureMedicamentosCytokinesOftalmologíaOriginal ArticleBCVA best corrected visual acuitymedicine.medical_specialtyOcular surface dysfunctionCorneal stainingContact LensesHyaluronic acidRE right eyeDEs dry eye syndrome03 medical and health sciencesOphthalmologyHumansAdverse effectbusiness.industryEyelidsEPA eicosapentaenoic acidAnatomía ocularIOP intraocular pressureeye diseasesClinical trialContact lensMOISTURIZING GEL030221 ophthalmology & optometryTearsLE left eyeEyelidsense organsbusiness030217 neurology & neurosurgeryOptometry
researchProduct

Distacco di retina regmatogeno primario ed opacità corneali.

2008

DISTACCO DI RETINA REGMATOGENOSettore MED/30 - Malattie Apparato VisivoOPACITA' CORNEALEPATOLOGIE RETINICHE
researchProduct

Quantitative corneal anatomy: evaluation of the effect of diabetes duration on the endothelial cell density and corneal thickness.

2014

Purpose To evaluate the differences in endothelial cell density (ECD) and central corneal thickness (CCT) between type II diabetic patients and age-matched healthy controls, and determine the impact of time from diagnosis. Methods This is a comparative study of 77 eyes of type II diabetic patients (33 males, 44 females) and 80 eyes of healthy subjects (42 males, and 38 females) whose ages ranged from 38 to 56 years. CCT, ECD, HbA1c levels, and Goldmann tonometry were measured. Results The CCT was significantly higher and the ECD significantly lower in long-term diabetic patients (10 years + since diagnosis) when compared with short-term diabetic patients (<1 year since diagnosis) and contro…

Diabetes durationAdultMalemedicine.medical_specialtyTime Factorsgenetic structuresCorneal PachymetryCell CountType ii diabetesCorneaHba1c levelOphthalmologyInternal medicineMedicineHumansRetrospective StudiesGlycated Hemoglobinbusiness.industryEndothelium CornealHealthy subjectsMiddle AgedCorneal structureeye diseasesSensory SystemsEndothelial cell densityGoldmann tonometryOphthalmologyEndocrinologyDiabetes Mellitus Type 2Disease ProgressionFemalesense organsAnalysis of variancebusinessOptometryOphthalmicphysiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)
researchProduct

Axial Length and Anterior Segment Alterations in Former Preterm Infants and Full-Term Neonates Analyzed With Scheimpflug Imaging.

2017

Purpose To compare the axial length and anterior segment alterations in preterm infants with and without retinopathy of prematurity with those of full-term infants. Methods The Wiesbaden Prematurity Study investigated 503 participants of former gestational age ≤32 weeks and gestational age ≥37 weeks now being aged 4 to 10 years. This study included 485 participants in the prospective controlled cross-sectional, hospital-based study with successful Pentacam Scheimpflug imaging. Anterior segment parameters, axial length measurements, and associated factors were analyzed. Results Corneal thickness did not differ between former preterm and full-term infants. Significant differences were found b…

Diagnostic ImagingMalePediatricsmedicine.medical_specialtyCorneal PachymetryTerm BirthBirth weightVisual AcuityGestational AgeAstigmatismRefraction Ocular03 medical and health sciences0302 clinical medicineAnterior Eye SegmentMedicineBirth WeightHumansProspective StudiesCorneal pachymetryChildFull Termmedicine.diagnostic_testbusiness.industryGestational ageRetinopathy of prematurityInfant Low Birth Weightmedicine.diseaseRefractive ErrorsOphthalmologyLow birth weightAxial Length EyeCross-Sectional Studies030221 ophthalmology & optometryTerm BirthFemalemedicine.symptombusiness030217 neurology & neurosurgeryInfant PrematureCornea
researchProduct

Proposal of a new diffractive corneal inlay to improve near vision in a presbyopic eye

2020

[EN] A new class of diffraction-based corneal inlays for treatment of presbyopia is described. The inlay is intended to achieve an improvement of the near focus quality over previous designs. Our proposal is a two-zone hybrid device with separated amplitude and phase areas having a central aperture and no refractive power. An array of micro-holes is distributed on the surface of the inlay conforming a binary photon sieve. In this way, the central hole of the disk contributes to the zero order of diffraction, and the light diffracted by the micro-holes in the peripheral photon sieve produces a real focus for near vision. We employed ray-tracing software to study the performance of the new in…

DiffractionApertureComputer scienceVisual AcuityOptical powerRefraction OcularDiffraction efficiencyModels Biological01 natural sciencesCorneaCorneal Transplantation010309 opticsOpticsOptical transfer function0103 physical sciencesMyopiamedicine03.- Garantizar una vida saludable y promover el bienestar para todos y todas en todas las edadesHumansComputer SimulationElectrical and Electronic EngineeringEngineering (miscellaneous)Vision BinocularInlaymedicine.diagnostic_testbusiness.industryCorneal TopographyPresbyopiaPresbyopiaModels Theoreticalmedicine.diseaseCorneal topographyCorneal inlayAtomic and Molecular Physics and OpticsPhoton sieveIntraocular lensesFISICA APLICADAbusinessOrbital ImplantsApplied Optics
researchProduct

Core-Shell Arginine-Containing Chitosan Microparticles for Enhanced Transcorneal Permeation of Drugs

2019

Chitosan oligosaccharide (C) was functionalized with L-arginine (A) and short hydrocarbon chains (C-8) to design an amphiphilic copolymer, henceforth CAC(8), leading to microparticles (MPs) consisting of an arginine-decorated hydrophilic shell and inner hydrophobic domains allowing the encapsulation of high amount hydrophobic drugs such as sorafenib tosylate (>10% w/w). L-arginine side chains were selected in order to impart the final MPs enhanced transcorneal penetration properties, thus overcoming the typical biological barriers which hamper the absorption of drugs upon topical ocular administration. The mucoadhesive properties and drug release profile of the CAC(8) MPs (CAC(8)-MPs) were …

Drug3003congenital hereditary and neonatal diseases and abnormalitiesArginineSwinemedia_common.quotation_subjectamphiphilic copolymerPharmaceutical ScienceL-arginineAdministration Ophthalmic02 engineering and technologyArginine030226 pharmacology & pharmacyCorneaChitosan03 medical and health scienceschemistry.chemical_compoundDrug Delivery Systems0302 clinical medicineMucoadhesionSide chainAnimalsskin and connective tissue diseasesProtein Kinase Inhibitorsmedia_commonMucin-3microparticlesDrug CarriersMucinnutritional and metabolic diseasesSorafenibPermeation021001 nanoscience & nanotechnologyCombinatorial chemistryBioavailabilityDrug LiberationmicroparticlechemistrySettore CHIM/09 - Farmaceutico Tecnologico Applicativoocular administrationchitosan0210 nano-technologymucoadhesion
researchProduct

Rapid in vitro test to predict ocular tissue permeability based on biopartitioning micellar chromatography.

2003

The drug permeability prediction across the ocular tissues is important in the development of new drugs and drug delivery strategies. Physicochemical characteristics of drugs, mainly acid-base character, hydrophobicity and the molecular size determine both their transport across the eye tissue barriers and their retention in biopartitioning micellar chromatography (BMC). An in vitro model able to describe and predict the whole cornea drug permeability is proposed. The model uses the retention of drugs in BMC and molecular weight (MW) as predictive variables. The relationships between drug retention data in BMC and their bibliographic permeability values in stroma, epithelium-plus-stroma and…

DrugOctanolsIn vitro testChemical Phenomenamedia_common.quotation_subjectPharmaceutical ScienceEyeModels BiologicalPermeabilityCorneaOcular tissueDrug permeabilityPredictive Value of TestsCorneamedicinemedia_commonChromatography Micellar Electrokinetic CapillaryChromatographyDrug discoveryChemistryChemistry PhysicalPermeability (earth sciences)medicine.anatomical_structureData Interpretation StatisticalDrug deliveryIndicators and ReagentsSpectrophotometry UltravioletEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

Novel inulin-based mucoadhesive micelles loaded with corticosteroids as potential transcorneal permeation enhancers

2017

In this work a new copolymer of inulin (INU) derivatized with ethylendiamine (EDA) and retinoic acid (RA), named INU-EDA-RA, was synthetized, characterized and employed to produce micelles as carriers for topical administration of corticosteroids for the potential treatment of diseases of posterior eye segment. Spectroscopic analysis confirmed a molar derivatization degree of 11.30 and 4.30% in EDA and RA, respectively. INU-EDA-RA micelles are capable of strong mucoadhesive interactions which result time-independent and stable over time but concentration depending. Moreover micelles are able to encapsulate efficiently from 3 to 13% (w/w) of lipophilic drugs, as dexamethasone, triamcinolone …

DrugTriamcinolone acetonideTranscorneal enhancerCell SurvivalSwineAdministration Topicalmedia_common.quotation_subjectTranswellPharmaceutical ScienceMucoadhesionRetinal Pigment Epithelium02 engineering and technologyOcular disease030226 pharmacology & pharmacyMicellePermeabilityCorneaMice03 medical and health sciences0302 clinical medicineAdrenal Cortex HormonesPolymeric micelleRetinoic acidCell AdhesionMucoadhesionmedicineCorticosteroidAnimalsHumansDissolution testingOcular topical administrationMicellesmedia_commonDrug CarriersChromatographyDose-Response Relationship DrugChemistryInulinGeneral Medicine021001 nanoscience & nanotechnologyPermeability (electromagnetism)Cattle0210 nano-technologyDrug carrierDrug metabolismBiotechnologymedicine.drugEuropean Journal of Pharmaceutics and Biopharmaceutics
researchProduct

DSAEK sottile e ultrasottile

2014

Dsaek cornea transplantation
researchProduct